GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Other Income (Expense)

Minapharm Pharmaceuticals (CAI:MIPH) Other Income (Expense) : E£-16 Mil (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Other Income (Expense)?

Minapharm Pharmaceuticals's other income expense for the Minapharm Pharmaceuticals's pretax income for the six months ended in Jun. 2024 was E£43 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was E£-16 Mil.

Minapharm Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Minapharm Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Other Income (Expense) Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
Other Income (Expense)
37.52 -37.47

Minapharm Pharmaceuticals Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Other Income (Expense) - 20.70 -58.17 42.63

Minapharm Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was E£-16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minapharm Pharmaceuticals  (CAI:MIPH) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Minapharm Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Other Income (Expense)
Comparable Companies
OSTO:INDEX TPE:1783 HKSE:00455 KAR:SAPL KAR:HINOON XKRX:118000 ROCO:1780 BOM:532649 BOM:531633 XKRX:052670 ALIM XKRX:014570 XLJU:SALR BSE:ATB XKRX:004720 LSE:FUM MIL:PRL TSE:4586 BOM:524500 LSE:AGY
Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Website
https://www.minapharm.com
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines